✦ LIBER ✦

Autoantibodies Reacting with Poly(ADP-Ribose) and with a Zinc-Finger Functional Domain of Poly(ADP-Ribose) Polymerase Involved in the Recognition of Damaged DNA

✍ Scribed by S. Muller; J.-P. Briand; S. Barakat; J. Lagueux; G.G. Poirier; G. De Murcia; D.A. Isenberg

Book ID: 112240563
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 655 KB
Volume: 73
Category: Article
ISSN: 1090-2341
DOI: 10.1006/clin.1994.1187

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Growth-phase-dependent response to DNA d

Growth-phase-dependent response to DNA damage in poly(ADP-ribose) polymerase deficient cell lines: basis for a new hypothesis describing the role of poly(ADP-ribose) polymerase in DNA replication and repair

✍ Satadal Chatterjee; Nathan A. Berger 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 838 KB

Zinc is an essential cofactor for recogn

Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases

✍ Patrice Decker; Jean-Paul Briand; Gilbert De Murcia; Ron W. Pero; David A. Isenb 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 925 KB

Combination effects of poly(ADP-ribose)

Combination effects of poly(ADP-ribose) polymerase inhibitors and DNA-damaging agents in ovarian tumor cell lines —with special reference to cisplatin

✍ Frithjof Bernges; W. Jens Zeller 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 669 KB

Txk, a member of the non-receptor tyrosi

Txk, a member of the non-receptor tyrosine kinase of the Tec family, forms a complex with poly(ADP-ribose) polymerase 1 and elongation factor 1α and regulates interferon-γ gene transcription in Th1 cells

✍ T. Maruyama; K. Nara; H. Yoshikawa; N. Suzuki 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 648 KB

Phase II, Open-Label, Randomized, Multic

Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer

✍ Kaye, S. B.; Lubinski, J.; Matulonis, U.; Ang, J. E.; Gourley, C.; Karlan, B. Y. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 165 KB

A randomized, placebo-controlled trial t

A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial

✍ David A. Morrow; Chaim M. Brickman; Sabina A. Murphy; Kenneth Baran; Ricardo Kra 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 258 KB